Indee Labs Closes $2.6M in Seed Funding From Founders Fund’s FF Science and Main Sequence VenturesPatients should not need to wait four months for these life-saving therapies SAN FRANCISCO, May 18, 2018-- Indee Labs received US$2.6M in venture financing extending its seed-stage funding to more than US$5.4M (AU$7.1M). This will accelerate the development of Indee Labs’ gene therapy manufacturing technology into a product that biotechnology companies can use for discovery-stage research. The round was led by Founders Fund (San Francisco) and included Main Sequence Ventures (Australia) along with several angels.